New active rehab program aims to get soldiers back on duty faster after concussion

NCT ID NCT05320822

Recruiting now Symptom relief Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a structured rehabilitation program for active-duty soldiers who have had a mild traumatic brain injury (concussion). The program includes low-intensity aerobic exercise, balance, and cognitive activities tailored to each soldier's symptoms and job demands. Researchers want to see if this approach helps soldiers recover faster and return to full duty compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Active rehabilitation program (low-intensity aerobic exercise, balance, and cognitive activities)
What this could lead to: If it works, this could help soldiers with concussion recover faster and return to duty sooner with fewer lingering symptoms.
What could go wrong: This is an early-phase trial with only 130 participants, so results may not apply to all concussion cases. The program may not speed recovery more than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONCUSSION, BRAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONCUSSION, BRAIN

Contacts and locations

Locations

United States Special Operations Command
RECRUITING

Fort Liberty, North Carolina, 28310, United States
Womack Army Medical Center
RECRUITING

Fort Liberty, North Carolina, 28310, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.